Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets
Open Access
- 12 October 2023
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 97, 104829
Abstract
No abstract availableKeywords
Funding Information
- Kreftforeningen (20060442)
- Helse Sør-Øst RHF (2020064)
This publication has 84 references indexed in Scilit:
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1Neuro-Oncology, 2012
- Copynumber: Efficient algorithms for single- and multi-track copy number segmentationBMC Genomics, 2012
- Camera: a competitive gene set test accounting for inter-gene correlationNucleic Acids Research, 2012
- Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancersBreast Cancer Research, 2011
- Nrg1/ErbB signaling networks in Schwann cell development and myelinationSeminars in Cell & Developmental Biology, 2010
- Allele-specific copy number analysis of tumorsProceedings of the National Academy of Sciences, 2010
- Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival geneEMBO Molecular Medicine, 2009
- Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTsSarcoma, 2008
- An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survivalProceedings of the National Academy of Sciences, 2005